Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the efficacy and safety of esketamine for reducing symptoms of major depressive disorder, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 3 | Status: RECRUITING